Circulation, Vol 77, 361-371, Copyright © 1988 by American Heart Association
PW Serruys, HE Luijten, KJ Beatt, R Geuskens, PJ de Feyter, M van den Brand, JH Reiber, HJ ten Katen, GA van Es and PG Hugenholtz
Data from experimental, clinical, and pathologic studies have suggested
that the process of restenosis begins very early after coronary
angioplasty. The present study was performed to determine prospectively the
incidence of restenosis with use of the four National Heart, Lung, and
Blood Institute and the 50% or greater diameter stenosis criteria, as well
as a criterion based on a decrease of 0.72 mm or more in minimal luminal
diameter. Patients were recatheterized at 30, 60, 90, or 120 days after
successful percutaneous transluminal coronary angioplasty (PTCA). After
PTCA all patients received 10 mg nifedipine three to six times a day and
aspirin once a day until repeat angiography. Of 400 consecutive patients in
whom PTCA was successful (less than 50% diameter stenosis), 342 underwent
quantitative angiographic follow-up (86%) by use of an automated
edge-detection technique. A wide variation in the incidence of restenosis
was found dependent on the criterion applied. The incidence of restenosis
proved to be progressive to at least the third month for all except NHLBI
criterion II. At 4 months a further increase in the incidence of restenosis
was observed when defined as a decrease of 0.72 mm or more in minimal
luminal diameter, whereas the criteria based on percentage diameter
stenosis showed a variable response. The lack of overlap between the
different restenosis criteria applied affirms the arbitrary nature of
angiographic definitions currently in use. Restenosis should be assessed by
repeat angiography, and preferably ascertained according to the change in
absolute quantitative measurements of the luminal diameter.
ARTICLES
Incidence of restenosis after successful coronary angioplasty: a time- related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months
Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.
This article has been cited by other articles:
![]() |
J. A. Ormiston and P. W.S. Serruys Bioabsorbable Coronary Stents Circ Cardiovasc Interv, June 1, 2009; 2(3): 255 - 260. [Full Text] [PDF] |
||||
![]() |
R. A. Byrne, R. Iijima, J. Mehilli, S. Pinieck, O. Bruskina, A. Schomig, and A. Kastrati Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beri Outcomes in the Era of Bare-Metal Stents vs the Era of Drug-Eluting Stents JAMA, January 7, 2009; 301(1): 33 - 33. [Full Text] [PDF] |
||||
![]() |
J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text] |
||||
![]() |
S.-F. Yan, E. Harja, M. Andrassy, T. Fujita, and A. M. Schmidt Protein Kinase C {beta}/Early Growth Response-1 Pathway: A Key Player in Ischemia, Atherosclerosis, and Restenosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A47 - A55. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Patel, S. Daniel, C. R. Longo, G. V. Shrikhande, S. T. Scali, E. Czismadia, C. M. Groft, T. Shukri, C. Motley-Dore, H. E. Ramsey, et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia FASEB J, July 1, 2006; 20(9): 1418 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lee, H.-C. Tan, and Y.-T. Lim Update on Drug-Eluting Stents for Prevention of Restenosis Asian Cardiovasc Thorac Ann, February 1, 2006; 14(1): 75 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mauri, E. J. Orav, and R. E. Kuntz Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison Circulation, June 28, 2005; 111(25): 3435 - 3442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Windecker, R. Simon, M. Lins, V. Klauss, F. R. Eberli, M. Roffi, G. Pedrazzini, T. Moccetti, P. Wenaweser, M. Togni, et al. Randomized Comparison of a Titanium-Nitride-Oxide-Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TiNOX Trial Circulation, May 24, 2005; 111(20): 2617 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, A. Ruebben, A. Mahnken, M. Stuber, C. Kolker, T. H. Nguyen, R. W. Gunther, and A. Buecker Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent Circulation, March 1, 2005; 111(8): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Steg, C. Thuaire, D. Himbert, D. Carrie, S. Champagne, D. Coisne, K. Khalife, P. Cazaux, D. Logeart, M. Slama, et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction Eur. Heart J., December 2, 2004; 25(24): 2187 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lemos, N. Mercado, R. T. van Domburg, R. E. Kuntz, W. W. O'Neill, and P. W. Serruys Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional Stenting Circulation, November 16, 2004; 110(20): 3199 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Giedd and S. R. Bergmann Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention J. Am. Coll. Cardiol., February 4, 2004; 43(3): 328 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bhargava, G. Karthikeyan, A. S Abizaid, and R. Mehran New approaches to preventing restenosis BMJ, July 31, 2003; 327(7409): 274 - 279. [Full Text] [PDF] |
||||
![]() |
G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, A. Ruebben, M. Stuber, R. W. Gunther, and A. Buecker Metallic Renal Artery MR Imaging Stent: Artifact-free Lumen Visualization with Projection and Standard Renal MR Angiography Radiology, June 1, 2003; 227(3): 897 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bonvini, I. Baumgartner, D. D. Do, M. Alerci, J.-M. Segatto, P. Tutta, K. Jager, M. Aschwanden, E. Schneider, B. Amann-Vesti, et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries J. Am. Coll. Cardiol., February 5, 2003; 41(3): 409 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Cutlip, M. S. Chauhan, D. S. Baim, K. K. L. Ho, J. J. Popma, J. P. Carrozza, D. J. Cohen, and R. E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Regar, P.W. Serruys, C. Bode, C. Holubarsch, J.L. Guermonprez, W. Wijns, A. Bartorelli, C. Constantini, M. Degertekin, K. Tanabe, et al. Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size Circulation, October 8, 2002; 106(15): 1949 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruscazio, R. Montisci, P. Colonna, C. Caiati, L. Chen, G. Lai, M. Cadeddu, R. Pirisi, and S. Iliceto Detection of coronary restenosis aftercoronary angioplasty by contrast-enhanced transthoracic echocardiographic Doppler assessment of coronary flow velocity reserve J. Am. Coll. Cardiol., September 4, 2002; 40(5): 896 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krueger, P. Landwehr, M. Bendel, M. Nolte, H. Stuetzer, R. Bongartz, M. Zaehringer, G. Winnekendonk, A. Gossmann, R.-P. Mueller, et al. Endovascular Gamma Irradiation of Femoropopliteal de Novo Stenoses Immediately after PTA: Interim Results of Prospective Randomized Controlled Trial Radiology, August 1, 2002; 224(2): 519 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dangas and F. Kuepper Restenosis: Repeat Narrowing of a Coronary Artery: Prevention and Treatment Circulation, June 4, 2002; 105(22): 2586 - 2587. [Full Text] [PDF] |
||||
![]() |
X. Wang and B. Paigen Comparative Genetics of Atherosclerosis and Restenosis: Exploration With Mouse Models Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 884 - 886. [Full Text] [PDF] |
||||
![]() |
G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O.M. Hess Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty Eur. Heart J., May 1, 2002; 23(9): 726 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arakawa, K. Hagisawa, H. Kusano, S. Yoneyama, A. Kurita, T. Arai, M. Kikuchi, I. Sakata, S.-i. Umenura, and F. Ohsuzu Sonodynamic Therapy Decreased Neointimal Hyperplasia After Stenting in the Rabbit Iliac Artery Circulation, January 15, 2002; 105(2): 149 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kanamasa, Y. Inoue, N. Otani, N. Naito, H. Morii, A. Ikeda, M. Taniguchi, N. Ishida, T. Hayashi, and K. Ishikawa tPA via Infusion Catheters Followed by Continuous IV Infusion for 3 Days Prevents Intimal Hyperplasia After Balloon Injury Angiology, December 1, 2001; 52(12): 819 - 825. [Abstract] [PDF] |
||||
![]() |
G. Schnyder, M. Roffi, R. Pin, Y. Flammer, H. Lange, F. R. Eberli, B. Meier, Z. G. Turi, and O. M. Hess Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels N. Engl. J. Med., November 29, 2001; 345(22): 1593 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF] |
||||
![]() |
J. George, S. Greenberg, I. Barshack, M. Singh, S. Pri-Chen, S. Laniado, and G. Keren Accelerated intimal thickening in carotid arteries of balloon-injured rats after immunization against heat shock protein 70 J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1564 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lambert, N. Malik, L. Shepherd, J. Gunn, S. E. Francis, A. King, D. C. Crossman, D. C. Cumberland, and C. M. Holt Localization of c-Myb and Induction of Apoptosis by Antisense Oligonucleotide c-myb After Angioplasty of Porcine Coronary Arteries Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1727 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Marx and A. R. Marks Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis Circulation, August 21, 2001; 104(8): 852 - 855. [Full Text] [PDF] |
||||
![]() |
Z. Chen, K. W. Woodburn, C. Shi, D. C. Adelman, C. Rogers, and D. I. Simon Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 759 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. t. Berg, B. A. Hutten, J. C. Kelder, F. W. A. Verheugt, and H. W. T. Plokker Oral Anticoagulant Therapy During and After Coronary Angioplasty : The Intensity and Duration of Anticoagulation Are Essential to Reduce Thrombotic Complications Circulation, April 24, 2001; 103(16): 2042 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.A Costa, L.E.A de Wit, V de Valk, P Serrano, A.J Wardeh, P.W Serruys, and W Sluiter Indirect evidence for a role of a subpopulation of activated neutrophils in the remodelling process after percutaneous coronary intervention Eur. Heart J., April 1, 2001; 22(7): 580 - 586. [Abstract] [PDF] |
||||
![]() |
C Hehrlein, A Kovacs, G.K Wolf, N Yue, and R Nath A novel balloon angioplasty catheter impregnated with beta-particle emitting radioisotopes for vascular brachytherapy to prevent restenosis. First in vivo results Eur. Heart J., December 2, 2000; 21(24): 2056 - 2062. [Abstract] [PDF] |
||||
![]() |
N. Ohashi, A. Matsumori, Y. Furukawa, K. Ono, M. Okada, A. Iwasaki, T. Miyamoto, A. Nakano, and S. Sasayama Role of p38 Mitogen-Activated Protein Kinase in Neointimal Hyperplasia After Vascular Injury Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2521 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kageyama, H. Yamamoto, and R. Yoshimoto Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2303 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
A G Violaris, A Thury, E Regar, R Melkert, and P W Serruys Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty Heart, September 1, 2000; 84(3): 299 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Rockson, D. P. Lorenz, W.-F. Cheong, and K. W. Woodburn Photoangioplasty : An Emerging Clinical Cardiovascular Role for Photodynamic Therapy Circulation, August 1, 2000; 102(5): 591 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. t. Berg, J. C. Kelder, M. J. Suttorp, E. G. Mast, E. Bal, S. M. P. G. Ernst, F. W. A. Verheugt, and H. W. T. Plokker Effect of Coumarins Started Before Coronary Angioplasty on Acute Complications and Long-Term Follow-Up : A Randomized Trial Circulation, July 25, 2000; 102(4): 386 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tamai, K. Igaki, E. Kyo, K. Kosuga, A. Kawashima, S. Matsui, H. Komori, T. Tsuji, S. Motohara, and H. Uehata Initial and 6-Month Results of Biodegradable Poly-l-Lactic Acid Coronary Stents in Humans Circulation, July 25, 2000; 102(4): 399 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Kuntz and D. S. Baim Prevention of Coronary Restenosis : The Evolving Evidence Base for Radiation Therapy Circulation, May 9, 2000; 101(18): 2130 - 2133. [Full Text] [PDF] |
||||
![]() |
I. Ogawa, T. Hayashi, T. Nakabayashi, N. Otani, K. Ishikawa, and K. Kanamasa Prevention of Coronary Arterial Renarrowing by Continuous 3-Day Infusion of Tissue Plasminogen Activator After Successful Percutaneous Transluminal Coronary Angioplasty: A Randomized, Double-Blind, Placebo-Controlled Study Angiology, May 1, 2000; 51(5): 367 - 375. [Abstract] [PDF] |
||||
![]() |
R.J.G Peters, W.E.M Kok, G Pasterkamp, C Von Birgelen, M Prins, and P.W Serruys Videodensitometric quantitative angiography after coronary balloon angioplasty, compared to edge-detection quantitative angiography and intracoronary ultrasound imaging Eur. Heart J., April 2, 2000; 21(8): 654 - 661. [Abstract] [PDF] |
||||
![]() |
S. Doucet, M. Malekianpour, P. Theroux, L. Bilodeau, G. Cote, Pierre de Guise, J. Dupuis, M. Joyal, G. Gosselin, J.-F. Tanguay, et al. Randomized Trial Comparing Intravenous Nitroglycerin and Heparin for Treatment of Unstable Angina Secondary to Restenosis After Coronary Artery Angioplasty Circulation, March 7, 2000; 101(9): 955 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jorgensen, S. Simonsen, K. Endresen, K. Forfang, K. Vatne, J. Hansen, J. Webb, C. Buller, G. Goulet, J. Erikssen, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) J. Am. Coll. Cardiol., March 1, 2000; 35(3): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kamenz, W. Seibold, M. Wohlfrom, S. Hanke, N. Heise, C. Lenz, and H. Hanke Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model Cardiovasc Res, February 1, 2000; 45(3): 766 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hozumi, K. Yoshida, T. Akasaka, Y. Asami, Y. Kanzaki, Y. Ueda, A. Yamamuro, T. Takagi, and J. Yoshikawa Value of acceleration flow and the prestenotic to stenotic coronary flow velocity ratio by transthoracic color doppler echocardiography in noninvasive diagnosis of restenosis after percutaneous transluminal coronary angioplasty J. Am. Coll. Cardiol., January 1, 2000; 35(1): 164 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindsay Jr., E. E. Pinnow, and A. D. Pichard Frequency of major adverse cardiac events within one month of coronary angioplasty: a useful measure of operator performance J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1916 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Betriu, M. Masotti, A. Serra, J. Alonso, F. Fernandez-Aviles, F. Gimeno, T. Colman, J. Zueco, J. L. Delcan, E. Garcia, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1498 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wardeh, I. P. Kay, M. Sabate, V. L. M. A. Coen, A. L. Gijzel, J. M. R. Ligthart, A. den Boer, P. C. Levendag, W. J. van der Giessen, and P. W. Serruys {beta}-Particle-Emitting Radioactive Stent Implantation : A Safety and Feasibility Study Circulation, October 19, 1999; 100(16): 1684 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Jorgensen, S Simonsen, K Endresen, K Forfang, T Egeland, A.T Hostmark, and E Thaulow Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids Eur. Heart J., October 1, 1999; 20(19): 1407 - 1414. [Abstract] [PDF] |
||||
![]() |
B. S Oemar Is interleukin-1 beta a triggering factor for restenosis? Cardiovasc Res, October 1, 1999; 44(1): 17 - 19. [Full Text] [PDF] |
||||
![]() |
A. Magdy, M. Al-Abbady, A. Ghoga, K. Heib, and C. Ozbek Restenosis After Angioplasty in Patients with Left Ventricular Dysfunction Asian Cardiovasc Thorac Ann, September 1, 1999; 7(3): 209 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. St. Pierre, L.-Y. Yang, K. Tamirisa, D. Scherrer, P. De Ciechi, P. Eisenberg, E. Tolunay, and D. Abendschein Tissue Factor Pathway Inhibitor Attenuates Procoagulant Activity and Upregulation of Tissue Factor at the Site of Balloon-Induced Arterial Injury in Pigs Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2263 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tsuchikane, A. Fukuhara, T. Kobayashi, M. Kirino, K. Yamasaki, T. Kobayashi, M. Izumi, S. Otsuji, H. Tateyama, M. Sakurai, et al. Impact of Cilostazol on Restenosis After Percutaneous Coronary Balloon Angioplasty Circulation, July 6, 1999; 100(1): 21 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Flaker, J. W. Warnica, F. M. Sacks, L. A. Moye, B. R. Davis, J. L. Rouleau, R. R. Webel, M. A. Pfeffer, E. Braunwald, and for the Cholesterol and Recurrent Events CARE Inve Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations J. Am. Coll. Cardiol., July 1, 1999; 34(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kop Chronic and Acute Psychological Risk Factors for Clinical Manifestations of Coronary Artery Disease Psychosom Med, July 1, 1999; 61(4): 476 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Helgeson and H. L. Fritz Cognitive Adaptation as a Predictor of New Coronary Events After Percutaneous Transluminal Coronary Angioplasty Psychosom Med, July 1, 1999; 61(4): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Salachas, S. P. Patsilinakos, K. P. Tsilias, I. Stefanou, N. G. Margaris, G. P. Ifantis, A. J. Kranidis, A. G. Tavernarakis, S. G. Rokas, and I. Antonellis Elective Intracoronary Micro-Stent IITM Implantation Without Quantitative Coronary Angiography or Intravascular Ultrasound Guidance and Without Subsequent Anticoagulation: Short- and Long-Term Results Angiology, May 1, 1999; 50(5): 381 - 391. [Abstract] [PDF] |
||||
![]() |
C. Manegold, M. Alwazzeh, H. Jablonowski, O. Adams, M. Medve, B. Seidlitz, U. Heidland, D. Haussinger, B.-E. Strauer, and M. P. Heintzen Prior Cytomegalovirus Infection and the Risk of Restenosis After Percutaneous Transluminal Coronary Balloon Angioplasty Circulation, March 16, 1999; 99(10): 1290 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wehinger, A. Kastrati, S. Elezi, H. Baum, S. Braun, F.-J. Neumann, and A. Schomig Lipoprotein(a) and coronary thrombosis and restenosis after stent placement J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bosmans, C. J. Vrints, M. M. Kockx, H. Bult, K. M. C. Cromheeke, and A. G. Herman Continuous Perivascular L-Arginine Delivery Increases Total Vessel Area and Reduces Neointimal Thickening After Experimental Balloon Dilatation Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 767 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. W. Bech, N. H. J. Pijls, B. De Bruyne, K. H. Peels, H. R. Michels, H. J. R. M. Bonnier, and J. J. Koolen Usefulness of Fractional Flow Reserve to Predict Clinical Outcome After Balloon Angioplasty Circulation, February 23, 1999; 99(7): 883 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Furukawa, A. Matsumori, N. Ohashi, T. Shioi, K. Ono, A. Harada, K. Matsushima, and S. Sasayama Anti–Monocyte Chemoattractant Protein-1/Monocyte Chemotactic and Activating Factor Antibody Inhibits Neointimal Hyperplasia in Injured Rat Carotid Arteries Circ. Res., February 19, 1999; 84(3): 306 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wilensky, K. Mehdi, K. M. Sowinski, Sang Hong Baek, and K. L. March Increased Intramural Retention After Local Delivery of Molecules with Increased Binding Properties: Implications for Regional Delivery of Pharmacologic Agents Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(2): 103 - 112. [Abstract] [PDF] |
||||
![]() |
D. A. Halon, M. Y. Flugelman, A. Merdler, H. Rennert, J. Shahla, and B. S. Lewis Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Malik, S. E. Francis, C. M. Holt, J. Gunn, G. L. Thomas, L. Shepherd, J. Chamberlain, C. M. H. Newman, D. C. Cumberland, and D. C. Crossman Apoptosis and Cell Proliferation After Porcine Coronary Angioplasty Circulation, October 20, 1998; 98(16): 1657 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bauriedel, S. Schluckebier, R. Hutter, U. Welsch, R. Kandolf, B. Luderitz, and M. F. Prescott Apoptosis in Restenosis Versus Stable-Angina Atherosclerosis : Implications for the Pathogenesis of Restenosis Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1132 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Janssens, D. Flaherty, Z. Nong, O. Varenne, N. van Pelt, C. Haustermans, P. Zoldhelyi, R. Gerard, and D. Collen Human Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Balloon Injury in Rats Circulation, April 7, 1998; 97(13): 1274 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Jenkins, M. T. Crow, C. Bilato, Y. Gluzband, W.-S. Ryu, Z. Li, W. Stetler-Stevenson, C. Nater, J. P. Froehlich, E. G. Lakatta, et al. Increased Expression of Membrane-Type Matrix Metalloproteinase and Preferential Localization of Matrix Metalloproteinase-2 to the Neointima of Balloon-Injured Rat Carotid Arteries Circulation, January 13, 1998; 97(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Achenbach, W. Moshage, and K. Bachmann Detection of High-Grade Restenosis After PTCA Using Contrast-Enhanced Electron Beam CT Circulation, November 4, 1997; 96(9): 2785 - 2788. [Abstract] [Full Text] |
||||
![]() |
H. Ueno, J.-J. Li, S. Masuda, Z. Qi, H. Yamamoto, and A. Takeshita Adenovirus-Mediated Expression of the Secreted Form of Basic Fibroblast Growth Factor (FGF-2) Induces Cellular Proliferation and Angiogenesis In Vivo Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2453 - 2460. [Abstract] [Full Text] |
||||
![]() |
R. Pakala, J. T. Willerson, and C. R. Benedict Effect of Serotonin, Thromboxane A2, and Specific Receptor Antagonists on Vascular Smooth Muscle Cell Proliferation Circulation, October 7, 1997; 96(7): 2280 - 2286. [Abstract] [Full Text] |
||||
![]() |
F.-C. Schoebel, F. Gradaus, K. Ivens, P. Heering, T. W. Jax, B. Grabensee, B.-E. Strauer, and M. Leschke Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography Heart, October 1, 1997; 78(4): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Essen, R. Ostermaier, E. Grube, W. Maurer, U. Tebbe, R. Erbel, M. Roth, W. Oel, J. Brom, G. Weidinger, et al. Effects of Octreotide Treatment on Restenosis After Coronary Angioplasty : Results of the VERAS Study Circulation, September 2, 1997; 96(5): 1482 - 1487. [Abstract] [Full Text] |
||||
![]() |
J. A. Ormiston, F. M. Stewart, A. H. G. Roche, B. J. Webber, R. M. L. Whitlock, and M. W. I. Webster Late Regression of the Dilated Site After Coronary Angioplasty : A 5-Year Quantitative Angiographic Study Circulation, July 15, 1997; 96(2): 468 - 474. [Abstract] [Full Text] |
||||
![]() |
T. Kimura, S. Kaburagi, T. Tamura, H. Yokoi, Y. Nakagawa, H. Yokoi, N. Hamasaki, H. Nosaka, M. Nobuyoshi, G. S. Mintz, et al. Remodeling of Human Coronary Arteries Undergoing Coronary Angioplasty or Atherectomy Circulation, July 15, 1997; 96(2): 475 - 483. [Abstract] [Full Text] |
||||
![]() |
D. S. Schwartz, G. H. Ribakove, E. A. Grossi, J. D. Schwartz, P. M. Buttenheim, F. G. Baumann, S. B. Colvin, and A. C. Galloway SINGLE AND MULTIVESSEL PORT-ACCESS CORONARY ARTERY BYPASS GRAFTING WITH CARDIOPLEGIC ARREST: TECHNIQUE AND REPRODUCIBILITY J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 46 - 52. [Abstract] [Full Text] |
||||
![]() |
M. Aikawa, Y. Sakomura, M. Ueda, K. Kimura, I. Manabe, S. Ishiwata, N. Komiyama, H. Yamaguchi, Y. Yazaki, and R. Nagai Redifferentiation of Smooth Muscle Cells After Coronary Angioplasty Determined via Myosin Heavy Chain Expression Circulation, July 1, 1997; 96(1): 82 - 90. [Abstract] [Full Text] |
||||
![]() |
E. Camenzind, W. H. Bakker, A. Reijs, I. M. van Geijlswijk, E. Boersma, M. J. B. Kutryk, E. P. Krenning, J. R. T. C. Roelandt, P. W. Serruys, and P. W. Serruys Site-Specific Intracoronary Heparin Delivery in Humans After Balloon Angioplasty : A Radioisotopic Assessment of Regional Pharmacokinetics Circulation, July 1, 1997; 96(1): 154 - 165. [Abstract] [Full Text] |
||||
![]() |
R. J.G. Peters, W. E.M. Kok, C. Di Mario, P. W. Serruys, F. W.H.M. Bar, G. Pasterkamp, C. Borst, O. Kamp, J. G.F. Bronzwaer, C. A. Visser, et al. Prediction of Restenosis After Coronary Balloon Angioplasty: Results of PICTURE (Post–IntraCoronary Treatment Ultrasound Result Evaluation), a Prospective Multicenter Intracoronary Ultrasound Imaging Study Circulation, May 6, 1997; 95(9): 2254 - 2261. [Abstract] [Full Text] |
||||
![]() |
J. M. Bosmans, M. M. Kockx, C. J. Vrints, H. Bult, G. R. Y. De Meyer, and A. G. Herman Fibrin(ogen) and von Willebrand Factor Deposition Are Associated With Intimal Thickening After Balloon Angioplasty of the Rabbit Carotid Artery Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 634 - 645. [Abstract] [Full Text] |
||||
![]() |
D. I. Simon, H. Xu, S. Ortlepp, C. Rogers, and N. K. Rao 7E3 Monoclonal Antibody Directed Against the Platelet Glycoprotein IIb/IIIa Cross-reacts With the Leukocyte Integrin Mac-1 and Blocks Adhesion to Fibrinogen and ICAM-1 Arterioscler Thromb Vasc Biol, March 1, 1997; 17(3): 528 - 535. [Abstract] [Full Text] |
||||
![]() |
F. Crawley, A. Clifton, H. Markus, and M. M. Brown Delayed Improvement in Carotid Artery Diameter After Carotid Angioplasty Stroke, March 1, 1997; 28(3): 574 - 579. [Abstract] [Full Text] |
||||
![]() |
M. J. Vonesh, L. F. Mockros, C. J. Davidson, K. B. Chandran, and D. D. McPherson In Vitro Identification of Angioplasty-Induced Injury by Use of Vascular Acoustic Emissions Circulation, February 18, 1997; 95(4): 1022 - 1029. [Abstract] [Full Text] |
||||
![]() |
E. A. Tovar and A. Borsari Effects of Surgical Manipulation on Coronary Stents: Should Surgical Strategy Be Altered? Ann. Thorac. Surg., January 1, 1997; 63(1): 37 - 40. [Abstract] [Full Text] |
||||
![]() |
Y. F. Zhou, M. B. Leon, M. A. Waclawiw, J. J. Popma, Z. X. Yu, T. Finkel, and S. E. Epstein Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary Atherectomy N. Engl. J. Med., August 29, 1996; 335(9): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ambrose and M. Weinrauch Thrombosis in Ischemic Heart Disease Arch Intern Med, July 8, 1996; 156(13): 1382 - 1394. [Abstract] [PDF] |
||||
![]() |
G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, S. Chiu Wong, M. K. Hong, J. A. Kovach, and M. B. Leon Arterial Remodeling After Coronary Angioplasty : A Serial Intravascular Ultrasound Study Circulation, July 1, 1996; 94(1): 35 - 43. [Abstract] [Full Text] |
||||
![]() |
S.-i. Ozeki, A. Ohtsuru, S. Seto, S. Takeshita, H. Yano, T. Nakayama, M. Ito, T. Yokota, M. Nobuyoshi, G. V. Segre, et al. Evidence That Implicates the Parathyroid Hormone–Related Peptide in Vascular Stenosis : Increased Gene Expression in the Intima of Injured Rat Carotid Arteries and Human Restenotic Coronary Lesions Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 565 - 575. [Abstract] [Full Text] |
||||
![]() |
K. G. Lehmann, R. Melkert, and P. W. Serruys Contributions of Frequency Distribution Analysis to the Understanding of Coronary Restenosis : A Reappraisal of the Gaussian Curve Circulation, March 15, 1996; 93(6): 1123 - 1132. [Abstract] [Full Text] |
||||
![]() |
R. Riessen, T. N. Wight, C. Pastore, C. Henley, and J. M. Isner Distribution of Hyaluronan During Extracellular Matrix Remodeling in Human Restenotic Arteries and Balloon-Injured Rat Carotid Arteries Circulation, March 15, 1996; 93(6): 1141 - 1147. [Abstract] [Full Text] |
||||
![]() |
P. A. Hardhammar, H. M.M. van Beusekom, H. U. Emanuelsson, S. H. Hofma, P. A. Albertsson, P. D. Verdouw, E. Boersma, P. W. Serruys, and W. J. van der Giessen Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries Circulation, February 1, 1996; 93(3): 423 - 430. [Abstract] [Full Text] |
||||
![]() |
R. L. Wilensky, K. L. March, I. Gradus-Pizlo, G. Sandusky, N. Fineberg, and D. R. Hathaway Vascular Injury, Repair, and Restenosis After Percutaneous Transluminal Angioplasty in the Atherosclerotic Rabbit Circulation, November 15, 1995; 92(10): 2995 - 3005. [Abstract] [Full Text] |
||||
![]() |
Y. Ozaki, D. Keane, and P. W. Serruys Progression and Regression of Coronary Stenosis in the Long-term Follow-up of Vasospastic Angina Circulation, November 1, 1995; 92(9): 2446 - 2456. [Abstract] [Full Text] |
||||
![]() |
E. Camenzind, P.-P. Kint, C. Di Mario, J. Ligthart, W. van der Giessen, E. Boersma, and P. W. Serruys Intracoronary Heparin Delivery in Humans : Acute Feasibility and Long-term Results Circulation, November 1, 1995; 92(9): 2463 - 2472. [Abstract] [Full Text] |
||||
![]() |
D. J. Cohen, H. M. Krumholz, C. A. Sukin, K. K.L. Ho, R. B. Siegrist, M. Cleman, R. R. Heuser, J. A. Brinker, J. W. Moses, M. P. Savage, et al. In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon Angioplasty : Results From a Randomized Clinical Trial Circulation, November 1, 1995; 92(9): 2480 - 2487. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |